Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Veriheal

AUGUST 24, 2022

This campaign was backed by New Approach PAC, a nationwide political organization that is focused on supporting progressive reform surrounding cannabis and criminal justice policies. So much, in fact, that it actually gained the attention of the DEA , which recently called for an increase in psychedelic production for research purposes.

Legalization 109

Legalization Decriminalization Medicine Research and Development 109

Cannabis Law Report

JULY 30, 2021

It also includes comprehensive restorative justice provisions, including grants, loans, and other funding programs for disadvantaged and minority businesses, record expungement, petitions for resentencing, and other measures intended to repair the decades of harm caused by the War on Drugs. Cannabis above 0.3%

Hemp 105

Hemp Law Seed-To-Sale Food 105

Project CBD

AUGUST 23, 2023

A leading California cannabis industry policy influencer, Devitt is currently Director of Regulatory Affairs at CannaCraft & March and Ash. 9 We cannot assume that these novel compounds are safe based on the safety profile of natural cannabinoids. .” percent on a dry weight basis.”

Cannabinoids 141

Cannabinoids Hemp THC Safety 141

CannaMD

SEPTEMBER 15, 2020

To learn more about telehealth appointments and CannaMD ‘s COVID-19 safety measures, see: Coronavirus Policies. In practice, the chances of feds or the DEA sitting at the border waiting to catch someone – that’s just not happening. The Florida Highway Patrol Policy Manual outlines these rights.

Law 126

Law Marijuana Patients Treatment 126

CannaMD

SEPTEMBER 10, 2020

This creates a somewhat confusing landscape for mothers who might benefit from cannabis-based therapies, but are also concerned for the safety of their child and the very real possibility of institutional intervention when marijuana use during pregnancy is documented. But despite these revelations, both messaging and legalities have lagged.

Marijuana 60

Marijuana Therapy Data THC 60

Canna Law Blog

MAY 7, 2020

At the same time, because of the federal illegality of cannabis, the federal government has routinely denied third party requests for further research in regards to its potential medical benefits, among other health and safety impacts. These cannabis products are used by researchers in the U.S.

DEA 71

DEA Research and Development Cultivation Supply Chain 71

Cannabis Law Report

MAY 1, 2019

8 In January of this year, Attorney General Jeff Sessions rescinded an Obama-era policy which had de-prioritized federal prosecution of those involved in the cannabis industry in states which had legalized medical or recreational cannabis. See Medicinal and Adult-Use Cannabis Regulation and Safety Act, Cal. FOOTNOTES. & Prof.

Legalization 45

Legalization Business Law Cannabis 45

Cannabis Law Report

NOVEMBER 2, 2021

Testing for Safety: Are Impurities a Problem? Testing for Safety: Are Impurities a Problem? At present, with almost no regulation over the industry, there is a definite risk of what chemist and hemp safety expert Dr. Matthew Curran describes to Refinery29 as “kitchen chemistry.” Table of Contents. Executive Summary.

THC 96

THC CBD Legalization Vaping 96

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 105

Law Research and Development Therapy DEA 105

Cannabis Law Report

SEPTEMBER 23, 2019

During the 20 th century, law enforcement and public policy activities have undermined opportunities for scientific exploration. Relevant AAFP Policy. Therefore, the AAFP advocates for further research into the overall safety and health effects of recreational use, as well as the effects of those laws on patient and societal health.

Cannabinoids 40

Cannabinoids Marijuana Research and Development Access 40

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

APRIL 8, 2022

Later that year, Doblin sued the DEA for the first time. The FDA formally decided to open the door to psychedelic research in human participants, and later accepted MAPS’ Phase 1 MDMA safety and tolerance study protocol. submitted his first DEA application to manufacture marijuana for use in medical research.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Meadow

JULY 13, 2018

Isa Perez (Head of Business Development at Meadow) moderates the Update from Local Regulators Panel with Joe Devlin (Sacramento Cannabis Policy and Enforcement), Cat Packer (Los Angeles Department of Cannabis Regulation), and Nicole Elliot ( San Francisco Office of Cannabis). Photo Credit: Kandid Kush.

Wellness and Beauty 40

Wellness and Beauty Consumption Policy Cannabis 40

Cannabis Law Report

APRIL 24, 2019

Such actions by the federal will create some very difficult paths because of policy distinctions arising from individual rights, public protections, commercial activities, health and safety, use of resources, etc.]. We are not going to attempt to tackle the myriad policy issues of this alternative, but we do have some observations.

Legalization 58

Legalization Collective DEA Banking 58

Cannabis Law Report

AUGUST 6, 2021

including building inventory and activating new production capacity along with higher third-party shipping, distribution and warehousing costs, partially offset by payroll subsidies received from the Canadian government in Q1 2022, pursuant to a COVID-19 relief program. Drug Enforcement Administration (the “DEA”), the U.S.

Vaping 105

Vaping Research and Development Data Business 105

The Cannigma

MAY 15, 2023

Ketamine has a long safety record as an anesthetic since the 1980s, and it has also been successfully used “off-label” for over a decade to treat conditions such as anxiety, depression, OCD, and PTSD, among others. What is treatment like through an at-home ketamine program? At-home ketamine treatment programs vary.

Therapy 78

Therapy Access Blood Pressure Treatment 78

The Cannigma

SEPTEMBER 12, 2021

The safety of using these products however, is still unknown. Marijuana (defined in the US as any cannabis plant where THC>0.3%) is a schedule I drug according to the DEA and FDA. Many states that disagreed with the federal approach to cannabis started their own medical marijuana programs, and made it accessible for patients.

THC 98

THC Research and Development Cannabinoids CBD 98

The Blunt Truth

MAY 15, 2020

Maine made changes to their marijuana program. We reported last week on the DOJ’s memo finding that the Drug Enforcement Administration’s cannabis research program is non-compliant with international drug laws. This move comes amidst an investigation into the medical marijuana program. No word yet on any change in policy.

Banking 106

Banking Research and Development Programs Advocacy 106

Canna Law Blog

NOVEMBER 16, 2021

The enforcement role moves from DEA to ATF. When it comes to enforcing federal cannabis regulations, the Drug Enforcement Administration (“DEA”) is out and the Bureau of Alcohol, Tobacco, Firearms, and Explosives (“ATF”) is in (in addition to TTB as the primary overseer). ” SBA fairness.

DEA 88

DEA Business Banking Food 88

Puff Puff Post

NOVEMBER 11, 2019

When it comes to drug policy, there’s still quite a bit of confusion, and the reality is that most people simply don’t know what scheduling is and how the system actually works. Following his announcement of a new “war on drugs” in 1971, Richard Nixon created the Drug Enforcement Administration (DEA) in 1973. Schedule 1. Psilocybin.

DEA 53

DEA History Legislation Banking 53

SMPL

FEBRUARY 11, 2020

President Trump proposed ending an existing policy that protects state medical marijuana programs from Justice Department interference as part of his fiscal year 2021 budget plan released on Monday. Questions remain regarding the safety of these compounds,” it continued.

Research and Development 40

Research and Development Legalization Marijuana Programs 40

Cannabis Law Report

MARCH 25, 2019

Both paths are complex processes in which scientific, medical, policy and political forces have influence. There are other avenues Congress can take besides rescheduling marijuana to ameliorate the seeming breakdown in federalism brought about by federal marijuana policy. It was not a policy priority of the Obama administration.

Banking 45

Banking Law Marijuana State Laws 45

Cannabis Law Report

AUGUST 5, 2021

State opt-out- States’ rights would be preserved with the authority of states to set their own marijuana policies and keep it illegal, but states would not be able to stop product from being transported through their state. There will also be a role for the Treasury and the Consumer Product Safety Commission. Still Unresolved.

Banking 111

Banking Vaping Education DEA 111

Cannabis Law Report

JULY 14, 2021

Legislation opens doors for cannabis policy reform in the current Congress. Cory Booker (D-NJ) and Ron Wyden (D-OR), released draft legislation today that would remove cannabis from the schedule of controlled substances while allowing states to determine their own cannabis policies. WASHINGTON, D.C. Senators Cory Booker, D-N.J.,

Legislation 71

Legislation Banking History Access 71

SMPL

MAY 6, 2020

A 2018 secret memo, released as part of the lawsuit settled, reveals the Trump Administration believes the nearly 50-year-old program in Mississippi has always been illegal. The National Institute of Drug Abuse (NIDA) manages the University of Mississippi program while Obama’s plan would run through the DEA.

DEA 40

DEA Marijuana Programs Cultivation 40

Cannabis Law Report

JANUARY 14, 2020

Senior Policy Advisor, Diversion Control Division. Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research. 171 , the “Legitimate Use of Medicinal Marihuana Act” or the “LUMMA” H.R. 601 , the “Medical Cannabis Research Act of 2019” H.R. Douglas Throckmorton, M.D.

Clinical Trials 69

Clinical Trials Programs Access DEA 69